This brief note highlights a translational advance with implications for mental health practice by showcasing a novel cellular approach to reducing pathological brain plaque, which is linked to cognitive decline. For clinicians across disciplines, the report illustrates how cutting-edge neuroscience strategies may influence future treatment paradigms, including the use of cell-based tools to modulate disease processes. The emphasis on leveraging native brain cells with targeted engineering demonstrates potential shifts in intervention development that could, over time, affect how neurodegenerative conditions are addressed within therapeutic settings.

Article Title: Scientists turn brain cells into Alzheimer’s plaque cleaners

Link to Science Daily Mind-Brain News: https://www dot sciencedaily dot com/releases/2026/03/260311004720 dot htm

#Alzheimer'sResearch #Neurotherapeutics #CellTherapy #BrainHealth #Neuroscience

Scientists turn brain cells into Alzheimer’s plaque cleaners
https://www dot sciencedaily dot com/releases/2026/03/260311004720 dot htm
Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy.
via Mind & Brain News -- ScienceDaily https://www dot sciencedaily dot com/news/mind_brain/
March 11, 2026 at 05:01PM

Copy and paste broken link above into your browser and replace "dot" with "." for link to work.

We have to do it this way to avoid display of copyrighted images.

Could autologous cell therapy be a next option in treatment of diabetic kidney disease?

Read the excellent blog post at NephJC

http://www.nephjc.com/news/rilprencel-react

#CKD #Diabetes #DKD #Medicine #Nephrology #CellTherapy

Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.

https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/

#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma

I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.

Here's an excellent update on research from my friend Paul Heltzel:

https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs

#diabetes #T1D #celltherapy #stemcell

🧫 Stem Cells — Jan 2026

• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment

https://pir.sh/xMNdAR2a6e

#StemCells #RegenerativeMedicine #CellTherapy #Biology

🧬 Gene Editing — Jan 2026

• CRISPR-Cas3 enables high-efficiency hepatic editing in vivo
• Advanced base editors expand precision mutagenesis capacity
• CAR-T approaches extend into autoimmune disease
• Editing and RNA regulation uncover new fibrosis and immune targets

#GeneEditing #CRISPR #CellTherapy #GenomicMedicine

https://pir.sh/zZXgkVNa2M